skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines brigatinibQuestion & answer

brigatinib · Medicine question

Which kinases does brigatinib target?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Brigatinib targets ALK, c-ros oncogene 1 (ROS1), and insulin-like growth factor 1 receptor (IGF-1R).

Sources for this answer

Alunbrig 30 mg film-coated tabletsTakeda UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 11Document updated 29 July 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

brigatinib

Read the wider context, including uses, precautions and the sources behind this medicine guide.

More questions about brigatinib

Can brigatinib be used during pregnancy?Can brigatinib cause high blood pressure?Can brigatinib increase sensitivity to sunlight?Do Alunbrig (brigatinib) 30 mg film-coated tablets require any special storage conditions?How much lactose monohydrate does each Alunbrig (brigatinib) 30 mg film-coated tablet contain?How should Alunbrig (brigatinib) tablets be swallowed?

Read the brigatinib guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX